SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 52 filers reported holding SCPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $150 | -99.9% | 21 | -99.8% | 0.00% | – |
| Q2 2023 | $103,164 | +4209.3% | 10,124 | +3734.8% | 0.00% | – |
| Q1 2023 | $2,394 | +28.4% | 264 | +1.5% | 0.00% | – |
| Q4 2022 | $1,864 | -37.9% | 260 | -44.1% | 0.00% | – |
| Q1 2021 | $3,000 | -50.0% | 465 | -61.4% | 0.00% | – |
| Q4 2020 | $6,000 | +100.0% | 1,206 | +258.9% | 0.00% | – |
| Q3 2020 | $3,000 | -40.0% | 336 | -52.3% | 0.00% | – |
| Q2 2020 | $5,000 | -28.6% | 704 | -26.1% | 0.00% | – |
| Q1 2020 | $7,000 | +40.0% | 953 | +24.3% | 0.00% | – |
| Q3 2019 | $5,000 | +66.7% | 767 | -25.2% | 0.00% | – |
| Q2 2019 | $3,000 | -40.0% | 1,025 | -39.0% | 0.00% | – |
| Q1 2019 | $5,000 | -28.6% | 1,679 | -8.2% | 0.00% | – |
| Q4 2018 | $7,000 | -61.1% | 1,828 | -39.4% | 0.00% | – |
| Q3 2018 | $18,000 | +28.6% | 3,017 | +20.5% | 0.00% | – |
| Q2 2018 | $14,000 | -97.1% | 2,503 | -93.5% | 0.00% | – |
| Q1 2018 | $481,000 | – | 38,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,207,009 | $15,713,904 | 7.44% |
| 5AM Venture Management, LLC | 1,200,647 | $8,548,607 | 2.46% |
| Worth Venture Partners, LLC | 539,665 | $3,842,415 | 2.28% |
| COWEN AND COMPANY, LLC | 1,795,647 | $12,785,006 | 0.90% |
| Orbimed Advisors | 5,559,528 | $39,583,839 | 0.84% |
| Rubric Capital Management LP | 2,713,287 | $19,318,603 | 0.72% |
| AlphaCentric Advisors LLC | 125,000 | $890,000 | 0.50% |
| RTW INVESTMENTS, LP | 3,297,843 | $23,480,642 | 0.50% |
| Tejara Capital Ltd | 101,414 | $722,068 | 0.41% |
| Leucadia National | 745,550 | $5,308,316 | 0.05% |